Below are the most recent publications written about "Economics, Pharmaceutical" by people in Profiles.
-
Najjar PA, Fields AC, Maldonado LJ, Ward A, Bleday R. Differential Index-Hospitalization Cost Center Impact of Enhanced Recovery After Surgery Program Implementation. Dis Colon Rectum. 2020 06; 63(6):837-841.
-
Tapper EB, Chhatwal J. We are Not Meeting the Needs of Pharmacoeconomic Models of Nonalcoholic Steatohepatitis, But We Can. Pharmacoeconomics. 2020 05; 38(5):427-429.
-
Faulkner E, Holtorf AP, Walton S, Liu CY, Lin H, Biltaj E, Brixner D, Barr C, Oberg J, Shandhu G, Siebert U, Snyder SR, Tiwana S, Watkins J, IJzerman MJ, Payne K. Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group. Value Health. 2020 05; 23(5):529-539.
-
Gorry C, McCullagh L, Barry M. Transferability of Economic Evaluations of Treatments for Advanced Melanoma. Pharmacoeconomics. 2020 02; 38(2):217-231.
-
Kaltenboeck A, Calsyn M, Frederix GWJ, Lowenthal J, Mitchell D, Rector B, Sarpatwari A. Grounding Value-Based Drug Pricing in Population Health. Clin Pharmacol Ther. 2020 06; 107(6):1290-1292.
-
Wylegala A, Paluch M, Orzechowska-Wylegala B, Galicka-Brzezina A, Chyrek K, Madej A. Pharmacoeconomic analysis of antibiotic therapy in surgical site infections?. Int J Clin Pharmacol Ther. 2019 Sep; 57(9):429-436.
-
Lee M, França UL, Graham RJ, McManus ML. Pre-Nusinersen Hospitalization Costs of Children With Spinal Muscular Atrophy. Pediatr Neurol. 2019 03; 92:3-5.
-
Robinson JC, Howell S, Pearson SD. Value-Based Pricing and Patient Access for Specialty Drugs. JAMA. 2018 Jun 05; 319(21):2169-2170.
-
Garrison LP, Neumann PJ, Willke RJ, Basu A, Danzon PM, Doshi JA, Drummond MF, Lakdawalla DN, Pauly MV, Phelps CE, Ramsey SD, Towse A, Weinstein MC. A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7]. Value Health. 2018 02; 21(2):161-165.
-
Ferrario A, Araja D, Bochenek T, Catic T, Dankó D, Dimitrova M, Fürst J, Greiciute-Kuprijanov I, Hoxha I, Jakupi A, Laidmäe E, Löblová O, Mardare I, Markovic-Pekovic V, Meshkov D, Novakovic T, Petrova G, Pomorski M, Tomek D, Voncina L, Haycox A, Kanavos P, Vella Bonanno P, Godman B. The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications. Pharmacoeconomics. 2017 Dec; 35(12):1271-1285.